In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867

Antimicrob Agents Chemother. 2005 Oct;49(10):4351-3. doi: 10.1128/AAC.49.10.4351-4353.2005.

Abstract

The in vitro activities of DA-7867, a novel oxazolidinone, and garenoxacin (BMS-284756) were compared to those of linezolid in 67 susceptible and drug-resistant clinical isolates of Mycobacterium tuberculosis. DA-7867 was the most active drug with an MIC(90) of 0.125 microg/ml, compared to the MIC(90)s of 4 microg/ml of garenoxacin and 2 microg/ml of linezolid.

Publication types

  • Comparative Study

MeSH terms

  • Acetamides / pharmacology
  • Antitubercular Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Resistance, Bacterial / drug effects*
  • Fluoroquinolones / pharmacology*
  • Linezolid
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / isolation & purification
  • Oxazolidinones / pharmacology*

Substances

  • Acetamides
  • Antitubercular Agents
  • DA-7867
  • Fluoroquinolones
  • Oxazolidinones
  • Linezolid
  • garenoxacin